MedTrace Logo

Pro-calcitonin Marker as Indicator of Ischemia in Patients With Complicated Coronary Intervention.

NCT01609569 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2013-02-22

No results posted yet for this study

Summary

The aim of this study is to determine on preliminary basis weather an elevated pro-calcitonin level can be used to assess ischemia as a result of coronary artery complications during percutaneous coronary intervention (PCI).

Conditions

  • Coronary Disease

Sponsors & Collaborators

  • Saint Michael's Medical Center

    lead OTHER

Principal Investigators

  • Habib Habib, MD · Saint Michael's Medical Center

  • Fayez Shamoon, MD,FACC · Saint Michael's Medical Center

  • yaser elnhar, MD · Saint Michael's Medical Center

  • Vincent Debari, PhD · Saint Michael's Medical Center

  • Ashraf Jmeian, MD · Saint Michael's Medical Center

  • Ahmad Isbitan, MD · Saint Michael's Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2014-04-30
Completion
2014-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01609569 on ClinicalTrials.gov